Window of Opportunity and Predictors of Sustained Remission in Patients with Hidradenitis Suppurativa Treated with Adalimumab: A 540-Patient Cohort Study
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease. Predicting responses of “prolonged disease-free remission” to biological therapy is essential for identifying a “window of opportunity” for disease modification. A retrospective multicenter cohort study (2015–2023) of 540 patients with HS treated wit...